In addition, AmerisourceBergen, Cardinal Health, and McKesson must require senior corporate officials to engage in regular oversight of anti-diversion efforts.
Furthermore, the settlement requires Johnson & Johnson to stop selling opioids for 10 years for term years; stop providing grants to third parties to promote opioids, and cease lobbying activities related to opioids.
The settlement also requires Johnson & Johnson to share clinical trial data under the Yale University Open Data Access Project.
———————————-
Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.
Want to contribute a story? We also accept article submissions – check out our writer’s guidelines here.
